Frontier Medicines Stock

frontiermeds.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $255.5MM

Frontier Medicines is a precision medicine company that develops breakthrough medicines for patients. Specifically, the company focuses on developing therapies for previously undruggable disease-causing proteins. Through its proprietary Frontier Platform, the company combines scientific approaches that include chemoproteomics, covalent drug discovery, and machine learning. Frontier Medicines was founded in 2018 by Chris Varma Ph.D and headquartered in San Francisco, CA.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Frontier Medicines, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Frontier Medicines’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Frontier Medicines.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Chris Varma Ph.D
Co-Founder, Chief Executive Officer & President
Roberto Zoncu Ph.D
Co-Founder & Advisor
Daniel Nomura Ph.D
Co-Founder & Advisor
Johannes Hermann Ph.D
Chief Technology Officer
Monique Bobadilla
Chief People and Culture Officer
Kevin Webster Ph.D
Chief Scientific Officer
Andrew Krivoshik MD
Chief Medical Officer
Gregory Chow
Chief Financial Officer

Board Members

Cameron Wheeler Ph.D
Deerfield Management
Derek DiRocco Ph.D
RA Capital Management
Luke Evnin Ph.D
MPM BioImpact

Frontier Medicines’ stock FAQs

plusminus

Can you buy Frontier Medicines’ stock?

As Frontier Medicines is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Frontier Medicines, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge's Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy Frontier Medicines’ stock?

To invest in a private company like Frontier Medicines’ through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge's marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Frontier Medicines’ stock?

Yes, you may be able to sell your Frontier Medicines’ stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Frontier Medicines’ stock?

If you hold private company shares of Frontier Medicines’ - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Frontier Medicines’ on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is Frontier Medicines’ a public company?

No, Frontier Medicines’ is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Frontier Medicines’ stock price?

Frontier Medicines is a privately held company and therefore does not have a public stock price. However, you may access Frontier Medicines’ private market stock price with Forge Data.
plusminus

What is Frontier Medicines’ stock ticker symbol?

Frontier Medicines does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Frontier Medicines Raises $80M in Series C, Targets Amgen and BMS in KRAS

Frontier Medicines on Thursday closed its oversubscribed $80 million Series C funding round, which it will use to advance its potentially first-in-class next-generation KRAS blocker FMC-376. The financing brings Frontier’s total capital raised to $235.5 million since its founding, according to the announcement. The funding round was co-led by Deerfield Management Company and Droia Ventures. Galapagos NV, a Belgium-based pharmaceutical company, participated as a strategic investor, along with contributions from MPM Capital, RA Capital Management and DCVC Bio.
Updated on: Jul 24, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.